Read how VistaGen’s intention to revolutionize mental health medicine is causing a buzz in the media.
Expert: There is a Dire Need to Improve, More Effectively Treat Mental Health Disorders for Returning Veterans
This Drug Has the Potential to Become the First FDA-Approved on-Demand Treatment for Social Anxiety
Psychiatric drugs were once a $30 billion business. Analysts say these 9 companies could revive it.
Karyopharm taps longtime Pfizer, Amgen vet to steer the ship; With Merck in the rearview mirror, Roger Perlmutter stakes his claim to a CEO job — and it's a surprising choice
Chutes & Ladders—Former Merck R&D chief Perlmutter takes reins at Eikon, applying Nobel-winning tech to drug discovery